Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Glaukos (GKOS) Research & Development (2016 - 2026)

Glaukos has reported Research & Development over the past 13 years, most recently at $44.1 million for Q1 2026.

  • Quarterly Research & Development rose 36.45% to $44.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $162.4 million through Mar 2026, up 17.64% year-over-year, with the annual reading at $150.6 million for FY2025, 10.4% up from the prior year.
  • Research & Development was $44.1 million for Q1 2026 at Glaukos, up from $43.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $44.1 million in Q1 2026 and troughed at $26.9 million in Q1 2022.
  • The 5-year median for Research & Development is $34.7 million (2024), against an average of $34.9 million.
  • Year-over-year, Research & Development dropped 12.64% in 2024 and then soared 36.45% in 2026.
  • A 5-year view of Research & Development shows it stood at $35.8 million in 2022, then rose by 3.49% to $37.1 million in 2023, then fell by 1.44% to $36.5 million in 2024, then rose by 19.5% to $43.7 million in 2025, then rose by 1.13% to $44.1 million in 2026.
  • Per Business Quant, the three most recent readings for GKOS's Research & Development are $44.1 million (Q1 2026), $43.7 million (Q4 2025), and $38.1 million (Q3 2025).